Document gEY8x5LMRDVagM1VayZn2Z5n3

DownloadSearchable PDFRandom document
To: Bruce Jarnot <jarnotb@api.org>; benzconsort-oc@listserve.api.org <benzconsort- oc@ listserve. api. org>; benzconsort-tc@ listserve. api. org <benzconsort-tc@ listserve. api. org>; benzene- erp@ listserve. api. org <benzene-erp@ listserve. api. org>; benzene-srp@ listserve. api. org <benzene- srp@listserve.api.org> From: Clegg, Patsy M SCC-CHSE-PC </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Matt Todd <ToddM@api.org>; Otto Wong (E-mail)<OttoWong@AOL.COM> Bcc: Received Date: 2004-02-12 16:58: 09 GMT Subject: RE: BHRC... Shanghai CC Study Progress Report for Jul-Dec, 2003 Question: Do we have a process in place to review the progress reports (excluding financials) to determine whether we believe that expectations are being met? I don't recall one. If not, let's give it some thought and discuss at our March call. Example: With the numbers provided by Otto on number of cases, we could start to build in the case accrual vs. financials that we discussed in November. Regards, Patsy Patsy Clegg Product Steward Shell Chemical LP One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals -----Original Message----From: Bruce Jarnot [mailto:jarnotb@api.org] Sent: Thursday, February 12, 2004 9:31 AM To: benzconsort-oc@listserve.api.org; benzconsort-tc@listserve.api.org; benzene-erp@listserve.api.org; benzene-srp@ listserve. api. org Cc: Matt Todd; Otto Wong (E-mail) Subject: BHRC... Shanghai CC Study Progress Report for Jul-Dec, 2003 Benzene Health Research Consortium (BHRC) Oversight Committee, Technical Committee, Science and Ethics Review Panels - Attached for your review and consideration is the latest Progress Report from Dr. Otto Wong on the AML and NHL Case Control (CC) Study, covering the period July - December 2003, along with a second file containing an organizational chart for the Shanghai project team -- both in Adobe pdf and Word doc formats. Please note that any large embedded question marks [???] in the pdf version of the progress report represent non-transcribed Chinese pictographic characters. This progress report and attachment will also soon be available on the Shanghai Health Study website. Similarly, API expects to soon receive a progress report for the Shanghai Disease Progression (DP) and Molecular Epidemiology (ME) studies from Dr. Richard Irons. With best regards - Bruce. ***** SH ELL-MCCLU RG-064163 Bruce M. Jarnot, Ph.D., DABT American Petroleum Institute Regulatory and Scientific Affairs 1220 L Street, NW (Suite 900) Washington, DC 20005-4070 phone: (202) 682-8473 fax: -8031 email: jarnotb@api.org SH ELL-MCCLU RG-064164